Cempra Inc. (NASDAQ:CEMP) was up 2% during mid-day trading on Wednesday . The company traded as high as $22.47 and last traded at $21.86, with a volume of 514,163 shares changing hands. The stock had previously closed at $21.44.

A number of equities research analysts recently issued reports on CEMP shares. Cowen and Company reissued a “buy” rating on shares of Cempra in a report on Tuesday, May 3rd. Roth Capital started coverage on shares of Cempra in a report on Tuesday, June 7th. They issued a “buy” rating and a $37.00 price objective for the company. Stifel Nicolaus dropped their price objective on shares of Cempra from $51.00 to $47.00 and set a “buy” rating for the company in a report on Friday, June 24th. Zacks Investment Research lowered shares of Cempra from a “buy” rating to a “hold” rating in a report on Thursday, August 11th. Finally, Jefferies Group dropped their price objective on shares of Cempra from $42.00 to $40.00 and set a “buy” rating for the company in a report on Tuesday, August 2nd. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $35.17.

The firm’s market capitalization is $1.13 billion. The company’s 50-day moving average is $20.76 and its 200-day moving average is $18.25.

Cempra (NASDAQ:CEMP) last released its quarterly earnings data on Monday, August 1st. The company reported ($0.51) EPS for the quarter, topping the consensus estimate of ($0.67) by $0.16. During the same quarter in the prior year, the firm earned ($0.57) earnings per share. The business earned $3.42 million during the quarter, compared to analysts’ expectations of $3.89 million. Cempra’s quarterly revenue was down 33.3% on a year-over-year basis. On average, equities research analysts expect that Cempra Inc. will post ($2.63) EPS for the current year.

An institutional investor recently raised its position in Cempra stock. Ameriprise Financial Inc. raised its stake in Cempra Inc. (NASDAQ:CEMP) by 78.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 62,281 shares of the company’s stock after buying an additional 27,438 shares during the period. Ameriprise Financial Inc. owned about 0.14% of Cempra worth $1,939,000 as of its most recent filing with the SEC.

Cempra, Inc is a clinical-stage pharmaceutical company. The Company is focused on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic staphylococcal infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.